Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ESLAW - Estrella Immunopharma Inc - Warrants (29/09/2028)


Previous close
0.1
0   0%

Share volume: 2,000
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.10
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
150.00%
1 Month
0   0%
3 Months
47.28%
6 Months
150.00%
1 Year
-37.50%
2 Year
-54.00%
Key data
Stock price
$0.10
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.03 - $0.34
52 WEEK CHANGE
-$0.67
MARKET CAP 
45.834 M
YIELD 
N/A
SHARES OUTSTANDING 
2.000 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,133
AVERAGE 30 VOLUME 
$3,591
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news